This app provides adult patients treated with KEYTRUDA® (pembrolizumab) easy access to information about their treatment
KeyCare
by Merck Sharp & Dohme Corp.
What is it about?
This app provides adult patients treated with KEYTRUDA® (pembrolizumab) easy access to information about their treatment.
App Store Description
This app provides adult patients treated with KEYTRUDA® (pembrolizumab) easy access to information about their treatment.
You must be a current patient on treatment with KEYTRUDA in Australia and be 18 years and older in order to access this app. If you cannot locate your access code, please contact your healthcare professional.
For MSD medical information, please contact: 1800 818 553.
Merck Sharp & Dohme (Australia) Pty Limited, Level 1, Building A, 26 Talavera Road, Macquarie Park NSW 2113, Australia. ONCO-1257980-0020 First issued Dec 2018
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.